1. Home
  2. RGNX vs APPS Comparison

RGNX vs APPS Comparison

Compare RGNX & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • APPS
  • Stock Information
  • Founded
  • RGNX 2008
  • APPS 2007
  • Country
  • RGNX United States
  • APPS United States
  • Employees
  • RGNX N/A
  • APPS N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • APPS Multi-Sector Companies
  • Sector
  • RGNX Health Care
  • APPS Miscellaneous
  • Exchange
  • RGNX Nasdaq
  • APPS Nasdaq
  • Market Cap
  • RGNX 459.1M
  • APPS 428.8M
  • IPO Year
  • RGNX 2015
  • APPS N/A
  • Fundamental
  • Price
  • RGNX $9.18
  • APPS $1.47
  • Analyst Decision
  • RGNX Strong Buy
  • APPS Hold
  • Analyst Count
  • RGNX 12
  • APPS 4
  • Target Price
  • RGNX $36.36
  • APPS $2.38
  • AVG Volume (30 Days)
  • RGNX 886.8K
  • APPS 5.7M
  • Earning Date
  • RGNX 11-06-2024
  • APPS 11-06-2024
  • Dividend Yield
  • RGNX N/A
  • APPS N/A
  • EPS Growth
  • RGNX N/A
  • APPS N/A
  • EPS
  • RGNX N/A
  • APPS N/A
  • Revenue
  • RGNX $84,327,000.00
  • APPS $491,574,000.00
  • Revenue This Year
  • RGNX $7.91
  • APPS N/A
  • Revenue Next Year
  • RGNX $214.75
  • APPS $9.83
  • P/E Ratio
  • RGNX N/A
  • APPS N/A
  • Revenue Growth
  • RGNX N/A
  • APPS N/A
  • 52 Week Low
  • RGNX $8.54
  • APPS $1.18
  • 52 Week High
  • RGNX $28.80
  • APPS $7.33
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 43.02
  • APPS 32.95
  • Support Level
  • RGNX $8.87
  • APPS $1.18
  • Resistance Level
  • RGNX $12.11
  • APPS $1.59
  • Average True Range (ATR)
  • RGNX 0.96
  • APPS 0.20
  • MACD
  • RGNX -0.05
  • APPS -0.08
  • Stochastic Oscillator
  • RGNX 17.17
  • APPS 12.66

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About APPS Digital Turbine Inc.

Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.

Share on Social Networks: